This work introduces a novel, facile and straightforward approach to produce cyclic-RGD-peptide-conjugated type II CdTe/CdS quantum dot (QD) formulation for pancreatic tumor targeting and imaging in live animals. The ultra-small QDs were prepared by a hot colloidal synthesis method. Phospholipid micelles were then used to encapsulate the QDs, allowing them to be stably dispersed in biological fluids and able to conjugate with cyclic-RGD peptides. The QD complex had shown low cytotoxicity on Panc-1 human pancreatic cancer cell lines. In addition, the tissue sections and biodistribution of QD complexes were imaged and analyzed in mice bearing pancreatic tumor xenografts, confirming specific tumor targeting. These studies support further evaluation of type II QDs as potential probes for early pancreatic cancer assessment and detection.

Keywords:
Nanotechnology, Targeted delivery, Quantum dots, Bioimaging, Nanotoxicity
1.
Yeo TP, Hruban RH, Leach SD, Wilentz RE, Sohn TA, Kern SE, Iacobuzio-Donahue CA, Maitra A, Goggins M, Canto MI, Abrams RA, Laheru D, Jaffee EM, Hidalgo M, Yeo CJ: Pancreatic cancer. Curr Prob Cancer 2004;26:176–275.
2.
Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CVE, Hruban RH, Lowy AM, Tuveson DA: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437–450
3.
Hruban RH, Maitra A, Kern SE, Goggins M: Precursors to pancreatic cancer. Gastroenterol Clin N Am 2007;36:831–849.
4.
Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, Hruban RH, Argani P: Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol 2004;35:357–366.
5.
Cao Q, Cai W, Li T, Yang Y, Chen K, Xing L, Chen X: Combination of integrin sirna and irradiation for breast cancer therapy. Biochem Biophys Res Commun 2006;351:726–732.
6.
Psimadas D, Fani M, Zikos C, Xanthopoulos S, Archimandritis SC, Varvarigou AD: Study of the labeling of two novel RGD- peptidic derivatives with the precursor [99mtc(H2O)3(CO)3]+ and evaluation for early angiogenesis detection in cancer. Appl Radiat Isotopes 2006;64:151–159.
7.
Cai W, Gambhir SS, Chen X: Molecular Imaging of Tumor Vasculature: Methods in Enzymology. New York, Academic Press, 2008, vol 45, chap 7, pp 141–176.
8.
Chen X, Park R, Shahinian AH, Bading JR, Conti PS: Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by pegylation. Nucl Med Biol 2004;31:11–19.
9.
Dobrucki LW, Sinusas AJ: Imaging angiogenesis. Curr Opin Biotechnol 2007;18:90–96.
10.
Chen X, Park R, Shahinian AH, Tohme M, Khankaldyyan V, Bozorgzadeh MH, Bading JR, Moats R, Laug WE, Conti PS: 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl Med Biol 2004;31:179–189.
11.
Juzenas P, Chen W, Sun Y-P, Coelho MAN, Generalov R, Generalova N, Christensen IL: Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev 2008;60:1600–1614.
12.
Li D, Li G, Guo W, Li P, Wang E, Wang J: Glutathione-mediated release of functional plasmid DNA from positively charged quantum dots. Biomaterials 2008;29:2776–2782.
13.
Yu WW, Chang E, Drezek R, Colvin VL: Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Commun 2006;348:781–786.
14.
Azzazy HME, Mansour MMH, Kazmierczak SC: From diagnostics to therapy: prospects of quantum dots. Clin Biochem 2007;40:917–927.
15.
Hild WA, Breunig M, Goepferich A: Quantum dots – nano-sized probes for the exploration of cellular and intracellular targeting. Eur J Pharmaceut Biopharmaceut 2008;68:153–168.
16.
Santos BS, Farias PMA, Fontes A, Mohamed H: Semiconductor Quantum Dots for Biological Applications: Handbook of Self Assembled Semiconductor Nanostructures for Novel Devices in Photonics and Electronics. Amsterdam, Elsevier, 2008, pp 773–798.
17.
Yong K-T, Sahoo Y, Swihart MT, Prasad PN: Growth of CDSE quantum rods and multipods seeded by noble metal nanoparticles. Adv Mater 2006;18:1978–1982.
18.
Dubertret B, Skourides P, Norris DJ, Noireaux V, Brivanlou AH, Libchaber A: In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 2002;298:1759–1762.
19.
Pan J, Feng S-S: Targeting and imaging cancer cells by folate-decorated, quantum dots (QDs)-loaded nanoparticles of biodegradable polymers. Biomaterials 2009;30:1176–1183.
20.
Yong KT, Qian J, Roy I, Lee HH, Bergey EJ, Tramposch KM, He S, Swihart MT, Maitra A, Prasad PN: Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells. Nano Lett 2007;7:761–765.
21.
Yong K-T, Roy I, Pudavar HE, Bergey EJ, Tramposch KM, Swihart MT, Prasad PN: Multiplex imaging of pancreatic cancer cells by using functionalized quantum rods. Adv Materials 2008;20:1412–1417.
22.
Sanvicens N, Marco MP: Multifunctional nanoparticles – properties and prospects for their use in human medicine. Trends Biotechnol 2008;26:425–433.
23.
Terai T, Nagano T: Fluorescent probes for bioimaging applications. Curr Opin Chem Biol 2008;12:515–521.
24.
Wang Y, Chen Y, Cai J, Zhong L: QD as a bifunctional cell-surface marker for both fluorescence and atomic force microscopy. Ultramicroscopy 2009;109:268–274.
25.
Tan WB, Huang N, Zhang Y: Ultrafine biocompatible chitosan nanoparticles encapsulating multi-coloured quantum dots for bioapplications. J Colloid Interface Sci 2007;310:464–470.
26.
Smith AM, Duan H, Mohs AM, Nie S: Bioconjugated quantum dots for in vivo molecular and cellular imaging. Adv Drug Deliv Rev 2008;60:1226–1240.
27.
Prasad PN: Introduction to Biophotonics. New York, Wiley-Interscience, 2004.
28.
Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV: Renal clearance of quantum dots. Nat Biotech 2007;25:1165–1170.
29.
Wang C, Zhang H, Zhang J, Li M, Sun H, Yang B: Application of ultrasonic irradiation in aqueous synthesis of highly fluorescent CdTe/CdS core-shell nanocrystals. J Phys Chem C 2007;111:2465–2469.
30.
Schreder B, Schmidt T, Ptatschek V, Winkler U, Materny A, Umbach E, Lerch M, Muller G, Kiefer W, Spanhel L: CdTe/CdS clusters with ‘core-shell’ structure in colloids and films: the path of formation and thermal breakup. J Phys Chem B 2000;104:1677–1685.
31.
Schöps O, Le Thomas N, Woggon U, Artemyev MV: Recombination dynamics of CdTe/CdS core-shell nanocrystals. J Phys Chem B 2006;110:2074–2079.
32.
Bao H, Gong Y, Li Z, Gao M: Enhancement effect of illumination on the photoluminescence of water-soluble CDTE nano crystals: toward highly fluorescent CdTe/CdS core-shell structure. Chem Materials 2004;16:3853–3859.
33.
He Y, Lu HT, Sai LM, Lai WY, Fan QL, Wang LH, Huang W: Microwave-assisted growth and characterization of water-dispersed CdTe/CdS core-shell nanocrystals with high photoluminescence. J Phys Chem B 2006;110:13370–13374.
34.
Yang L, Mao H, Cao Z, Wang YA, Peng X, Wang X, Sajja HK, Wang L, Duan H, Ni C, Staley CA, Wood WC, Gao X, Nie S: Molecular imaging of pancreatic cancer in a preclinical animal tumor model using targeted multifunctional nanoparticles. Gastroenterology. In press, uncorrected proof.
35.
Cho SJ, Maysinger D, Jain M, Roder B, Hackbarth S, Winnik FM: Long-term exposure to cdte quantum dots causes functional impairments in live cells. Langmuir 2007;23:1974–1980.
36.
Gao X, Cui Y, Levenson RM, Chung LWK, Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotech 2004;22:969–976.
37.
Cai W, Shin DW, Chen K, Gheysens O, Cao Q, Wang SX, Gambhir SS, Chen X: Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett 2006;6:669–676.
38.
Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, Shi X, Yuan H, Zhang C, Liu R, Zhao F, Zhao Y, Fang X: Bio-distribution and metabolic paths of silica coated CDSEs quantum dots. Toxicol Appl Pharmacol 2008;230:364–371.
39.
Gao X, Chen J, Chen J, Wu B, Chen H, Jiang X: Quantum dots bearing lectin-functionalized nanoparticles as a platform for in vivo brain imaging. Bioconjugate Chem 2008;19:2189–2195.
40.
Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS: Noninvasive imaging of quantum dots in mice. Bioconjugate Chem 2004;15:79–86.
41.
Ballou B, Ernst LA, Andreko S, Harper T, Fitzpatrick JAJ, Waggoner AS, Bruchez MP: Sentinel lymph node imaging using quantum dots in mouse tumor models. Bioconjugate Chem 2007;18:389–396.
42.
Li J-L, Wang L, Liu X-Y, Zhang Z-P, Guo H-C, Liu W-M, Tang S-H: In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett 2009;274:319–326.
43.
Papagiannaros A, Levchenko T, Hartner W, Mongayt D, Torchilin V: Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region. Nanomed Nanotechnol Biol Med. In press, corrected proof.
44.
Zhang G, Yang Z, Lu W, Zhang R, Huang Q, Tian M, Li L, Liang D, Li C: Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 2009;30:1928–1936.
45.
Zhang X, Chen X: Preparation and characterization of 99mtc(co)3-bpy-RGD complex as [alpha]v[beta]3 integrin receptor-targeted imaging agent. Appl Radiat Isotopes 2007;65:70–78.
46.
Kennel SJ, Woodward JD, Rondinone AJ, Wall J, Huang Y, Mirzadeh S: The fate of mab-targeted cd125mte/zns nanoparticles in vivo. Nucl Med Biol 2008;35:501–514.
47.
Maysinger D, Lovric J, Eisenberg A, Savic R: Fate of micelles and quantum dots in cells. Eur J Pharmaceut Biopharmaceut 2007;65:270–281.
48.
Su Y, He Y, Lu H, Sai L, Li Q, Li W, Wang L, Shen P, Huang Q, Fan C: The cytotoxicity of cadmium based, aqueous phase – synthesized, quantum dots and its modulation by surface coating. Biomaterials 2009;30:19–25.
49.
Erogbogbo F, Yong K-T, Roy I, Xu G, Prasad PN, Swihart MT: Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano 2008;2:873–878.
© 2010 S. Karger AG, Basel and IAP
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.